Showing results (351-360 of 427) with videos related to

Sort By:
Pageof 43
Acta Oncologica (Stockholm, Sweden)|September 9, 2021
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational studyFabio Stagno, Massimo Breccia, Mario Annunziata, et al.
Leukemia|April 23, 2026
ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitorsAndreas Hochhaus, Philipp le Coutre, Dragana Milojkovic, et al.
Blood|July 21, 2010
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA GroupFrancesco Lo-Coco, Giuseppe Avvisati, Marco Vignetti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2016
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysisMassimo Breccia, Guendalina Graffigna, Sara Galimberti, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 13, 2017
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric RegistryFlavia Mayer, Laura Faglioni, Nera Agabiti, et al.
Hematological Oncology|October 17, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biasesRoberta Soscia, Irene Della Starza, Lucia Anna De Novi, et al.
American Journal of Hematology|February 6, 2015
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemiasLuana Fianchi, Livio Pagano, Alfonso Piciocchi, et al.
Leukemia & Lymphoma|November 6, 2020
Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemiaFabio Efficace, Alessandra Iurlo, Andrea Patriarca, et al.
Annals of Hematology|November 27, 2023
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinibOlga Mulas, Elisabetta Abruzzese, Luigiana Luciano, et al.
Hematological Oncology|February 16, 2021
Impact of comorbidities and body mass index on the outcome of polycythemia vera patientsGiulia Benevolo, Elena M Elli, Daniela Bartoletti, et al.
Pageof 43